ABBV position history
The shares of AbbVie (ABBV) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 19,753 shares, $2.1M, 0.33% of portfolio
- 2021 Q4: 20,529 shares, $2.8M, 0.41% of portfolio, Add +3.9%
- 2022 Q1: 16,826 shares, $2.7M, 0.44% of portfolio, Reduce −18.0%
- 2022 Q2: 17,032 shares, $2.6M, 0.50% of portfolio, Add +1.2%
- 2022 Q3: 18,249 shares, $2.4M, 0.49% of portfolio, Add +7.1%
- 2022 Q4: 18,488 shares, $3M, 0.54% of portfolio, Add +1.3%
- 2023 Q1: 18,717 shares, $3M, 0.54% of portfolio, Add +1.2%
- 2023 Q2: 18,744 shares, $2.5M, 0.44% of portfolio, Add +0.1%
- 2023 Q3: 21,190 shares, $3.2M, 0.56% of portfolio, Add +13.0%
- 2023 Q4: 20,601 shares, $3.2M, 0.52% of portfolio, Reduce −2.8%
- 2024 Q1: 42,441 shares, $7.7M, 1.2% of portfolio, Add +106.0%
- 2024 Q2: 21,544 shares, $3.7M, 0.55% of portfolio, Reduce −49.2%
- 2024 Q3: 21,564 shares, $4.3M, 0.60% of portfolio, Add +0.1%
- 2024 Q4: 30,671 shares, $5.5M, 0.78% of portfolio, Add +42.2%
- 2025 Q1: 25,847 shares, $5.4M, 0.81% of portfolio, Reduce −15.7%
- 2025 Q2: 95,042 shares, $18M, 2.6% of portfolio, Add +267.7%
- 2025 Q3: 101,632 shares, $24M, 3.2% of portfolio, Add +6.9%
- 2025 Q4: 92,687 shares, $21M, 3.0% of portfolio, Reduce −8.8%
- 2026 Q1: 93,588 shares, $20M, 3.0% of portfolio, Add +1.0%
- 2026 Q2: 82,602 shares, $21M, 2.8% of portfolio, Reduce −11.7%
- 2026 Q3: 83,376 shares, $22M, 2.9% of portfolio, Add +0.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|